BBR Partners’s CVS Health CVS Stock Holding History

BBR Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,934	Closed	-$553K	–	229
2024 Q1	$553K	Buy	+6,934	New	+$530K	0.04%	136
2022 Q3	–	Sell	-2,932	Closed	-$272K	–	191
2022 Q2	$272K	Hold	2,932	–	–	0.03%	174
2022 Q1	$297K	Sell	2,932 -966	-25%	-$101K	0.03%	181
2021 Q4	$402K	Buy	3,898 +948	+32%	+$87.6K	0.05%	131
2021 Q3	$250K	Hold	2,950	–	–	0.02%	192
2021 Q2	$246K	Sell	2,950 -2,289	-44%	-$187K	0.02%	172
2021 Q1	$394K	Buy	5,239 +285	+6%	+$20.8K	0.03%	144
2020 Q4	$338K	Buy	4,954 +47	+1%	+$3.06K	0.03%	136
2020 Q3	$287K	Buy	+4,907	New	+$305K	0.02%	145
2019 Q2	–	Sell	-3,759	Closed	-$203K	–	128
2019 Q1	$203K	Buy	3,759 +678	+22%	+$41.8K	0.03%	126
2018 Q4	$202K	Sell	3,081 -62	-2%	-$4.63K	0.03%	130
2018 Q3	$247K	Buy	+3,143	New	+$225K	0.04%	97
2016 Q1	–	Sell	-3,453	Closed	-$338K	–	77
2015 Q4	$338K	Buy	+3,453	New	+$338K	0.05%	47

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BBR Partners's CVS Position: Q2 2024 in Review

BBR Partners sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,934 shares — an estimated $553K sold.

BBR Partners first reported a position in CVS in Q4 2015 and held it in 13 quarters. The position peaked at $553K in Q1 2024. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

BBR Partners reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
BBR Partners sold 6,934 CVS Health shares in Q2 2024, an estimated $553K.
BBR Partners first reported a position in CVS Health in Q4 2015 and held it in 13 quarters.
BBR Partners's CVS Health position peaked at $553K in Q1 2024.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on BBR Partners's 13F filing for Q2 2024, filed 5 Aug 2024.